Tenderwize
Back to tender search

Open House Discount Agreement for Zolmitriptan

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 222 days left·Open·Supplies
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Zolmitriptan, ATC N02CC03

50/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

The authority reserves the right to replace Open House agreements with exclusive discount agreements during the contrac...

No estimated value or volume is provided, so the potential business volume is unknown.

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of pharmaceutical products containing Zolmitriptan (ATC N02CC03)
  • Non-exclusive discount agreements with uniform conditions
Show full summary

This is an Open House (non-exclusive) discount agreement procedure by AOK Rheinland-Pfalz/Saarland for pharmaceutical products containing the active substance Zolmitriptan (ATC N02CC03). The contracting authority offers uniform, non-negotiable contracts to any interested pharmaceutical company without selection. Contracts run for a maximum of 24 months starting from June 1, 2025, with the possibility of joining on the first of any month. The procedure is explicitly stated not to be a public procurement under EU directive 2014/24/EU but is published for transparency. No estimated value is provided. Submission is paper-based only. The initial deadline for the first wave of contracts is April 30, 2025; later joiners must submit by the end of the month prior to the desired start.

Risks

The authority reserves the right to replace Open House agreements with exclusive discount agreements during the contrac...

No estimated value or volume is provided, so the potential business volume is unknown.

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Products must be authorized and marketable in Germany
  • Evidence of marketability via Lauer-Taxe listing or AMIce database extract

Administrative

  • Paper-based submission (electronic submission not allowed)

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria specified; contracts are offered on a take-it-or-leave-it basis to all participants.

Buyer

Lots (1)

LOT-0001

Open House Discount Agreement for Zolmitriptan

Non-exclusive discount agreements for Zolmitriptan (ATC N02CC03) under an Open House model. All interested pharmaceutical companies can join under uniform terms. Contracts may be terminated early if the authority awards exclusive discount agreements via a separate tendering process. The maximum contract duration is 24 months. Children's medicines according to BfArM list are excluded.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Award Criteria

No award criteria specified; contracts are offered on a take-it-or-leave-it basis to all participants.

Deadline

Deadline Mar 31, 2027

Procurement Details

Publication date
10 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
237213-2025

Documents (1)

Similar tenders